Skip to main content
Clinical Trials/NCT01384227
NCT01384227
Completed
Early Phase 1

Evaluation of a Miniaturized Microscope Device for the Detection of Barrett's Neoplasia: A Pilot Study

Anandasabapathy, Sharmila, M.D.1 site in 1 country40 target enrollmentFebruary 2009

Overview

Phase
Early Phase 1
Intervention
Proflavine Hemisulfate
Conditions
Barrett's Esophagus
Sponsor
Anandasabapathy, Sharmila, M.D.
Enrollment
40
Locations
1
Primary Endpoint
To determine whether tissue is neoplastic or non-neoplastic
Status
Completed
Last Updated
10 years ago

Overview

Brief Summary

The overall objective of this study is to obtain data to evaluate whether high-resolution imaging of barrett's esophagus in vivo can assist clinicians in detecting dysplastic (precancerous) areas. This is a pilot study of an novel technology, a miniaturized microscope device which can be used during upper endoscopy to image the gastrointestinal epithelium. This is an exploratory, not a comparative, study designed to evaluate the feasibility of using this instrument in Barrett's esophagus.

Registry
clinicaltrials.gov
Start Date
February 2009
End Date
July 2011
Last Updated
10 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Sponsor
Anandasabapathy, Sharmila, M.D.
Responsible Party
Principal Investigator
Principal Investigator

Sharmila Anandasabapathy, MD

Associate Professor of Medicne

Anandasabapathy, Sharmila, M.D.

Eligibility Criteria

Inclusion Criteria

  • Barrett's without dysplasia
  • Barrett's with dysplasia
  • Esophageal Adenocarcinoma

Exclusion Criteria

  • Subjects unfit for standard upper endoscopy
  • Subjects currently receiving chemo or radiation treatment
  • Subject currently receiving PDT or ablation

Arms & Interventions

Proflavine Hemisulfate

Intervention: Proflavine Hemisulfate

Outcomes

Primary Outcomes

To determine whether tissue is neoplastic or non-neoplastic

Time Frame: 1 day

Study Sites (1)

Loading locations...

Similar Trials